Considering the molecular mechanisms of FH, it appears clear that genetic variants in APOB and PCSK9 should be carefully evaluated for FH pathogenicity because they can be causative of two opposite phenotypes, but their evaluation is essential also for variants in the LDLR gene. The gene discussed is APOB; the disease is familial hyperaldosteronism.